Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.
Zhang Y, Wang Y, Jia C, Li G, Zhang W, Li Q, Chen X, Leng W, Huang L, Xie Z, Zhang H, You W, An R, Jiang H, Zhao X, Cheng S, Tan J, Cui W, Gao F, Lu W, Wang Y, Yang Y, Xia S, Wang S.
Zhang Y, et al. Among authors: wang y, wang s.
Vaccine. 2022 Aug 12;40(34):4933-4941. doi: 10.1016/j.vaccine.2022.06.078. Epub 2022 Jul 7.
Vaccine. 2022.
PMID: 35810063
Clinical Trial.